188 related articles for article (PubMed ID: 22595990)
21. Peroxisome proliferator ameliorates endothelial dysfunction in a murine model of hyperhomocysteinemia.
Sood HS; Hunt MJ; Tyagi SC
Am J Physiol Lung Cell Mol Physiol; 2003 Feb; 284(2):L333-41. PubMed ID: 12533311
[TBL] [Abstract][Full Text] [Related]
22. X-ray imaging of differential vascular density in MMP-9-/-, PAR-1-/+, hyperhomocysteinemic (CBS-/+) and diabetic (Ins2-/+) mice.
Givvimani S; Sen U; Tyagi N; Munjal C; Tyagi SC
Arch Physiol Biochem; 2011 Feb; 117(1):1-7. PubMed ID: 20839901
[TBL] [Abstract][Full Text] [Related]
23. Matrix metalloproteinase-9 inhibition reduces inflammation and improves motility in murine models of postoperative ileus.
Moore BA; Manthey CL; Johnson DL; Bauer AJ
Gastroenterology; 2011 Oct; 141(4):1283-92, 1292.e1-4. PubMed ID: 21703213
[TBL] [Abstract][Full Text] [Related]
24. Hydrogen sulfide regulates homocysteine-mediated glomerulosclerosis.
Sen U; Munjal C; Qipshidze N; Abe O; Gargoum R; Tyagi SC
Am J Nephrol; 2010; 31(5):442-55. PubMed ID: 20395677
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of cardiovascular remodeling in hyperhomocysteinemia.
Steed MM; Tyagi SC
Antioxid Redox Signal; 2011 Oct; 15(7):1927-43. PubMed ID: 21126196
[TBL] [Abstract][Full Text] [Related]
26. Activation of GABA-A receptor ameliorates homocysteine-induced MMP-9 activation by ERK pathway.
Tyagi N; Gillespie W; Vacek JC; Sen U; Tyagi SC; Lominadze D
J Cell Physiol; 2009 Jul; 220(1):257-66. PubMed ID: 19308943
[TBL] [Abstract][Full Text] [Related]
27. Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol.
Mishra PK; Tyagi N; Sen U; Joshua IG; Tyagi SC
Cardiovasc Diabetol; 2010 Sep; 9():49. PubMed ID: 20828387
[TBL] [Abstract][Full Text] [Related]
28. Hydrogen sulfide alleviates hyperhomocysteinemia-mediated skeletal muscle atrophy via mitigation of oxidative and endoplasmic reticulum stress injury.
Majumder A; Singh M; Behera J; Theilen NT; George AK; Tyagi N; Metreveli N; Tyagi SC
Am J Physiol Cell Physiol; 2018 Nov; 315(5):C609-C622. PubMed ID: 30110564
[TBL] [Abstract][Full Text] [Related]
29. Severe hyperhomocysteinemia promotes bone marrow-derived and resident inflammatory monocyte differentiation and atherosclerosis in LDLr/CBS-deficient mice.
Zhang D; Fang P; Jiang X; Nelson J; Moore JK; Kruger WD; Berretta RM; Houser SR; Yang X; Wang H
Circ Res; 2012 Jun; 111(1):37-49. PubMed ID: 22628578
[TBL] [Abstract][Full Text] [Related]
30. Hyperhomocysteinemia and atherosclerosis.
Yang F; Tan HM; Wang H
Sheng Li Xue Bao; 2005 Apr; 57(2):103-14. PubMed ID: 15830093
[TBL] [Abstract][Full Text] [Related]
31. Homocysteine decreases blood flow to the brain due to vascular resistance in carotid artery.
Kumar M; Tyagi N; Moshal KS; Sen U; Kundu S; Mishra PK; Givvimani S; Tyagi SC
Neurochem Int; 2008 Dec; 53(6-8):214-9. PubMed ID: 18725259
[TBL] [Abstract][Full Text] [Related]
32. Hydrogen Sulfide Protects Hyperhomocysteinemia-Induced Renal Damage by Modulation of Caveolin and eNOS Interaction.
Pushpakumar S; Kundu S; Sen U
Sci Rep; 2019 Feb; 9(1):2223. PubMed ID: 30778103
[TBL] [Abstract][Full Text] [Related]
33. Mitochondrial matrix metalloproteinase activation decreases myocyte contractility in hyperhomocysteinemia.
Moshal KS; Tipparaju SM; Vacek TP; Kumar M; Singh M; Frank IE; Patibandla PK; Tyagi N; Rai J; Metreveli N; Rodriguez WE; Tseng MT; Tyagi SC
Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H890-7. PubMed ID: 18567713
[TBL] [Abstract][Full Text] [Related]
34. Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine beta-synthase-deficient mice.
Zhang D; Jiang X; Fang P; Yan Y; Song J; Gupta S; Schafer AI; Durante W; Kruger WD; Yang X; Wang H
Circulation; 2009 Nov; 120(19):1893-902. PubMed ID: 19858416
[TBL] [Abstract][Full Text] [Related]
35. Synergism between AT1 receptor and hyperhomocysteinemia during vascular remodeling.
Sen U; Herrmann M; Herrmann W; Tyagi SC
Clin Chem Lab Med; 2007; 45(12):1771-6. PubMed ID: 17990952
[TBL] [Abstract][Full Text] [Related]
36. Nitration-mediated deficiency of cystathionine β-synthase activity accelerates the progression of hyperhomocysteinemia.
Wang H; Sun Q; Zhou Y; Zhang H; Luo C; Xu J; Dong Y; Wu Y; Liu H; Wang W
Free Radic Biol Med; 2017 Dec; 113():519-529. PubMed ID: 29102635
[TBL] [Abstract][Full Text] [Related]
37. Exercise mitigates the effects of hyperhomocysteinemia on adverse muscle remodeling.
Winchester LJ; Veeranki S; Pushpakumar S; Tyagi SC
Physiol Rep; 2018 Mar; 6(6):e13637. PubMed ID: 29595876
[TBL] [Abstract][Full Text] [Related]
38. Folic acid mitigates angiotensin-II-induced blood pressure and renal remodeling.
Pushpakumar SB; Kundu S; Metreveli N; Sen U
PLoS One; 2013; 8(12):e83813. PubMed ID: 24386282
[TBL] [Abstract][Full Text] [Related]
39. Toll-like receptor 4 mutation suppresses hyperhomocysteinemia-induced hypertension.
Familtseva A; Chaturvedi P; Kalani A; Jeremic N; Metreveli N; Kunkel GH; Tyagi SC
Am J Physiol Cell Physiol; 2016 Oct; 311(4):C596-C606. PubMed ID: 27488663
[TBL] [Abstract][Full Text] [Related]
40. Homocysteine alters cerebral microvascular integrity and causes remodeling by antagonizing GABA-A receptor.
Lominadze D; Tyagi N; Sen U; Ovechkin A; Tyagi SC
Mol Cell Biochem; 2012 Dec; 371(1-2):89-96. PubMed ID: 22886392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
